Comprehensive Validation of a Real-Time Quantitative bcr-abl Assay for Clinical Laboratory Use

1 July 2003

journal article
research article
Published by Oxford University Press (OUP) in American Journal of Clinical Pathology

Vol. 120 (1) , 42-48
https://doi.org/10.1309/60a9-c8wg-eghr-nxee

Abstract

We developed and extensively validated a real-time PCR assay for the quantitation of bcr-abl to determine residual disease in patients with chronic myelogenous leukemia. This method quantitates the p210 and the p190 bcr-abl RNA fusion transcripts with results normalized to a housekeeping gene, using the 5'-exonuclease technique and the ABI PRISM 7700 Sequence Detection System (Applied Biosystems, Foster City, CA). We parallel tested 372 clinical specimens and 50 peripheral blood samples from patients not known to have any myeloproliferative disorders. The results were 100% specific. Sensitivity studies showed that this method can detect bcr-abl in cell lines diluted to 0.0001% and can detect a single bcr-abl plasmid spiked into negative RNA. The between-run reproducibility showed a coefficient of variance (CV) of 12.3%, and within-run reproducibility showed a CV of 13.8%. This method can be used to reliably monitor the disease load in patients with bcr-abl–positive diseases.

Keywords

This publication has 17 references indexed in Scilit:

Early detection of BCR-ABL transcripts by quantitative reverse transcriptase–polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia
Blood, 2001
The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage
Annals of Hematology, 2000
Detection and quantification of residual disease in chronic myelogenous leukemia
Leukemia, 2000
Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR
Leukemia, 1999
Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation
Leukemia, 1999
BCR/ABL and leukemia
Leukemia Research, 1996
BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.
Molecular and Cellular Biology, 1991
Induction of Chronic Myelogenous Leukemia in Mice by the P210 ^bcr/abl Gene of the Philadelphia Chromosome
Science, 1990
Myelomonocytic leukaemia with a preleukaemic syndrome and Ph1 chromosome in monozygotic twins.
Archives of Disease in Childhood, 1977
Polycythemia Rubra Vera Progressing to Ph^1-Positive Chronic Myelogenous Leukemia
Annals of Internal Medicine, 1975